Text Size
128 studies found for:    juvenile arthritis

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
Conditions: Polyarticular Juvenile Idiopathic Arthritis;   Juvenile Idiopathic Arthritis;   Juvenile Rheumatoid Arthritis;   Extended Oligoarthritis Juvenile Idiopathic Arthritis
Interventions: Drug: methotrexate;   Drug: methotrexate, etanercept, prednisolone
2 Recruiting Juvenile Idiopathic Arthritis (JIA) Registry
Condition: Juvenile Idiopathic Arthritis
Interventions: Biological: adalimumab;   Drug: Methotrexate
3 Completed Ultrasonography in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis, Oligoarthritis;   Polyarticular Juvenile Rheumatoid Arthritis;   Systemic Juvenile Idiopathic Arthritis
Intervention: Device: Ultrasonography
4 Recruiting Jointstrong Intervention for Juvenile Arthritis
Condition: Juvenile Arthritis
Interventions: Behavioral: CD-ROM;   Behavioral: Wait-list Control Group
5 Active, not recruiting
Has Results 		A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra];   Drug: Placebo;   Drug: Non-steroidal anti-inflammatory drugs (NSAIDs);   Drug: methotrexate;   Drug: corticosteroids
6 Recruiting Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Conditions: Uveitis;   Juvenile Arthritis
Interventions: Drug: Anti-tumor necrosis factor alpha monoclonal antibody;   Drug: placebo
7 Active, not recruiting Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults
Condition: Juvenile Idiopathic Arthritis
Intervention: Biological: Rilonacept
8 Not yet recruiting Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
9 Terminated Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Interventions: Drug: Enbrel;   Drug: Placebo
10 Terminated Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Intervention: Drug: Infliximab
11 Completed BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo
12 Terminated
Has Results 		Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab;   Drug: Placebo
13 Active, not recruiting An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: Canakinumab
14 Recruiting A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)
Condition: Juvenile Idiopathic Arthritis
Interventions: Biological: CNTO 148 (Golimumab);   Biological: CNTO 148 (golimumab) or placebo
15 Completed Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
Condition: Systemic-Onset Juvenile Idiopathic Arthritis
Interventions: Drug: Anakinra;   Biological: Pneumo23
16 Not yet recruiting Cost of Care for Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
17 Completed
Has Results 		Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Intervention: Biological: Adalimumab
18 Completed Effect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Device: Galileo (whole body vibration (WBV) therapy)
19 Active, not recruiting Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Infliximab plus methotrexate;   Drug: Combination of DMARDs;   Drug: Methotrexate alone
20 Not yet recruiting An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab - Cohort 1;   Drug: Canakinumab - Cohort 2
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years